| Carriedelle Fusco, FNP | |
|
123 Hendersonville Rd, Asheville, NC 28803 | |
| (828) 257-4730 | |
| (828) 257-4738 |
| Full Name | Carriedelle Fusco |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 23 Years |
| Location | 123 Hendersonville Rd, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972875557 | NPI | - | NPPES |
| 1972875557 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 5005460 (North Carolina) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 209836 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain Area Health Education Center Inc | 0143206599 | 129 |
News Archive
Conventional health facility based HIV testing is plagued with poor rates of testing and has been around for the past 15+ years. Further, about 40-60% of individuals tested in facilities are lost to follow up.
Suneva Medical, a privately-held aesthetic medical device company, provided a research grant to support an investigator-sponsored research study to evaluate the degree of correction and patient satisfaction after injection of atrophic scars with Artefill. The data was presented by Dr. James Spencer, the grant recipient and study investigator, in a poster session at the 2010 Orlando Dermatology Conference taking place in Orlando, Florida January 15-18th.
As the first Australian to win the Tour de France, cycling champion Cadel Evans has already pedalled his way into our hearts. Now he is taking part in world-leading cardiopulmonary research – by pedalling inside an MRI scanner.
Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.
For the first time, researchers at LSU Health New Orleans have shown that a protein critical to the body's ability to remove waste products from the brain and retina is diminished in age-related macular degeneration, after first making the discovery in an Alzheimer's disease brain. The research team, led by Walter Lukiw, PhD, Professor of Neurology, Neuroscience and Ophthalmology at LSU Health New Orleans Neuroscience Center, also discovered a key reason, identifying a new treatment target.
› Verified 5 days ago
| Entity Name | Mountain Area Health Education Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952356388 PECOS PAC ID: 0143206599 Enrollment ID: O20040625000988 |
News Archive
Conventional health facility based HIV testing is plagued with poor rates of testing and has been around for the past 15+ years. Further, about 40-60% of individuals tested in facilities are lost to follow up.
Suneva Medical, a privately-held aesthetic medical device company, provided a research grant to support an investigator-sponsored research study to evaluate the degree of correction and patient satisfaction after injection of atrophic scars with Artefill. The data was presented by Dr. James Spencer, the grant recipient and study investigator, in a poster session at the 2010 Orlando Dermatology Conference taking place in Orlando, Florida January 15-18th.
As the first Australian to win the Tour de France, cycling champion Cadel Evans has already pedalled his way into our hearts. Now he is taking part in world-leading cardiopulmonary research – by pedalling inside an MRI scanner.
Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.
For the first time, researchers at LSU Health New Orleans have shown that a protein critical to the body's ability to remove waste products from the brain and retina is diminished in age-related macular degeneration, after first making the discovery in an Alzheimer's disease brain. The research team, led by Walter Lukiw, PhD, Professor of Neurology, Neuroscience and Ophthalmology at LSU Health New Orleans Neuroscience Center, also discovered a key reason, identifying a new treatment target.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carriedelle Fusco, FNP 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 257-4730 | Carriedelle Fusco, FNP 123 Hendersonville Rd, Asheville, NC 28803 Ph: (828) 257-4730 |
News Archive
Conventional health facility based HIV testing is plagued with poor rates of testing and has been around for the past 15+ years. Further, about 40-60% of individuals tested in facilities are lost to follow up.
Suneva Medical, a privately-held aesthetic medical device company, provided a research grant to support an investigator-sponsored research study to evaluate the degree of correction and patient satisfaction after injection of atrophic scars with Artefill. The data was presented by Dr. James Spencer, the grant recipient and study investigator, in a poster session at the 2010 Orlando Dermatology Conference taking place in Orlando, Florida January 15-18th.
As the first Australian to win the Tour de France, cycling champion Cadel Evans has already pedalled his way into our hearts. Now he is taking part in world-leading cardiopulmonary research – by pedalling inside an MRI scanner.
Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.
For the first time, researchers at LSU Health New Orleans have shown that a protein critical to the body's ability to remove waste products from the brain and retina is diminished in age-related macular degeneration, after first making the discovery in an Alzheimer's disease brain. The research team, led by Walter Lukiw, PhD, Professor of Neurology, Neuroscience and Ophthalmology at LSU Health New Orleans Neuroscience Center, also discovered a key reason, identifying a new treatment target.
› Verified 5 days ago